Robin Lesley

Robin Lesley is an accomplished professional in the field of biomedical sciences with a focus on immunology and oncology. Currently serving as the Director and Translational Medicine Lead for Hematology at AstraZeneca since January 2021, Robin previously held roles at Amgen, including Sr. Scientist - Clinical Biomarker Lead and Scientist - Clinical Biomarkers and Diagnostics in Oncology. At Genentech, Robin contributed as a Sr. Research Associate in Research Pathology, managing multiple oncology and immunology research projects. Prior experience includes a postdoctoral fellowship at the University of Washington and a PhD in BioMedical Sciences - Immunology from the University of California, San Francisco, complemented by a BS in Biology from Stanford University.